Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |